In order to understand the life span of VCu200 IUDs in situ, the copper-ion concentrations in the cervical mucus were assayed after insertion of VCu200 IUDs for 5 years. Copper-ion concentrations were measured at random in 30 cases each of 1, 3, 6, and 12 monthth VCu 200 IUD users and 20 cases each of 24, 36, 48, and 60 month users. At the same time, 10 cases of the inserted-ring users were similarly studied for comparison. In addition, to obtain the normal copper-ion concentrations in the cervical mucus during the proliferative phase (8th-9th day), mid-period phase (10th-14th day) and the secretory phase (20th-23rd day) of a norma cycle, 16 cases of nonusers were selected as control. The measurements were assayed by a non-flame atomic absorption spectrophotometer. Samples of 0.2-0.4 gms of cervical mucus were collected in a glass tube from the IUD users on the 20th-23rd day of the menstrual period. There is a significant difference between VCu200 IUD users and nonusers (p 0.01) and ring users (p 0.01). The copper-ions released in VCu200 IUD users in different months were 2.61, 1.98, 1.96, 1.82, 1.22, 1.20, 1.15, 0.98 ug/g. w. w., respectively. The equation for regression line is y = -0.2764x+2.2340, which shows that the amount released decreased wtih increased time interval. However, the released amount of copper-ions at the end of 60 months was still higher in the users than in the nonusers (p 0.05). These results indicate that VCu200 IUDs can be left in situ at least 5 years without decreasing its biological activity in contraception.
Download full-text PDF |
Source |
---|
BMC Womens Health
December 2024
Department of Obstetrics and Gynecology, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Introduction: IUDs are effective, reversible and safe methods of contraception. The mechanism of action of IUDs as a group is inducing endometrial atrophy, apoptosis, altering tubal motility; preventing sperm permeability, fertilization, and implantation. Complications of IUD include menstrual disturbance, pelvic pain, and increased risk of ectopic pregnancy with contraceptive failure, device expulsion, uterine perforation or transmural migration with misplacement of the device.
View Article and Find Full Text PDFInfect Dis Rep
December 2024
Microbial Biotechnology Laboratory, Department of Marine Biotechnology, Bharathidasan University, Tiruchirappalli 620024, India.
Indwelling intrauterine contraceptive devices (IUDs) have surfaces that facilitate the attachment of spp., creating a suitable environment for biofilm formation. Due to this, vulvovaginal candidiasis (VVC) is frequently linked to IUD usage, necessitating the prompt removal of these devices for effective treatment.
View Article and Find Full Text PDFBiol Psychol
December 2024
Department of Experimental Psychology and Helmholtz Institute, Utrecht University, the Netherlands. Electronic address:
Hormonal contraceptives (HC) such as the oral contraceptive pill (OC) and the hormonal intrauterine device (IUD) have been associated with depressed mood, but research on their role in anxiety is scarce and inconsistent. In a fear acquisition and extinction paradigm, self-report fear, expectancy, and skin conductance responses (SCR) were assessed, along with sex hormone levels. Naturally cycling (NC) participants were measured during the mid-follicular and mid-luteal phases (within subjects, n = 26) and compared with OC (n = 36) and IUD (n = 25) users.
View Article and Find Full Text PDFCureus
November 2024
Obstetrics and Gynaecology, East Suffolk and North Essex NHS Foundation Trust, Colchester, GBR.
We present a rare case involving a 25-year-old woman who had fragmentation of a copper intrauterine contraceptive device (IUD) while still within its recommended lifespan. The patient's symptoms included lower abdominal pain, offensive vaginal discharge, and the passage of copper IUD fragments. The pelvic examination confirmed the presence of the copper IUD strings, and with her consent, the device was removed.
View Article and Find Full Text PDFFront Glob Womens Health
November 2024
WHO Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Background: Contraceptives play a crucial role in women's reproductive health, their hormonal components may be linked to cancer risks, specifically breast, and gynecological cancers. Given the high usage rates of hormonal contraceptives, it is vital to systematically evaluate their potential impact on cancer outcomes, especially among women with a family history of gynecological cancers.
Objectives: This study aims to evaluate the evidence on the association between modern contraceptive use and the risk of breast and reproductive cancers (ovarian, endometrial, and cervical cancer) among women of reproductive age, to inform healthcare providers, women, and program managers about cancer outcomes related to contraceptive use.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!